Previous Article | Next Article ![]()
Journal of Virology, May 2001, p. 4823-4831, Vol. 75, No. 10
Department of Virology, Lerner Research
Institute,1 and Drug Discovery and
Experimental Therapeutics,2 Taussig Cancer
Center, The Cleveland Clinic Foundation, Cleveland, Ohio 44195
Received 22 September 2000/Accepted 20 February 2001
Interferon (IFN)-induced 2'-5' oligoadenylate synthetase (2-5A
synthetase)/RNase L, PKR, and Mx proteins are considered to be the
principal antiviral protein pathways through which IFN induces an
antiviral state. It was previously reported that human parainfluenza
virus type 3 (HPIV3) multiplication was inhibited by IFN-
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4823-4831.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Interferon Action against Human Parainfluenza Virus
Type 3: Involvement of a Novel Antiviral Pathway in the Inhibition
of Transcription
in human
lung epithelial cells A549 and that MxA was found to contribute to the
inhibition process (Zhao et al., Virology 220:330-338, 1996). Viral
primary transcription was dramatically inhibited in A549 cells after
IFN-
treatment, but a step following primary transcription was
inhibited in U87-MxA cells constitutively expressing MxA. Here we have
investigated the role of MxA, believed to be cell type specific, and
other antiviral pathways in the inhibition of viral primary
transcription. Our data indicate that a novel IFN-induced pathway(s) is
involved in the inhibition of primary transcription. This is based on
the following findings: (i) IFN-
inhibited viral primary
transcription in U87-MxA and other cell types including cells lacking
MxA; (ii) cells constitutively expressing 2-5A synthetase had no
antiviral effect against HPIV3; and (iii) primary transcription
occurred in the absence of protein synthesis, a step of PKR target. The
novel antiviral pathway(s) was induced by both IFN-
and IFN-
to
establish an effective antiviral state against HPIV3. By using
IFN-
-signaling mutant cells, we found that IFN-
could elicit
antiviral effect against HPIV3 without cross talk with the
IFN-
-signaling pathway. These data provide the first evidence that a
novel antiviral pathway(s) contributes to the antiviral action of IFN
against a nonsegmented negative-strand RNA virus by targeting the
primary transcription.
*
Corresponding author. Present address: The Arthur and
Rochelle Belfer Gene Therapy Core Facility, Weill Medical College of Cornell University, 515 East 71st St., Room S1000, New York, NY 10021. Phone: (212) 746-5627. Fax: (212) 746-8796. E-mail:
bpd2001{at}med.cornell.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»